| ²é¿´: 176 | »Ø¸´: 1 | ||
Çç·ïÒÇгæ (СÓÐÃûÆø)
|
[ÇóÖú]
΢Æ×Êý¾ÝÇóÖú
|
| 16.20,30.63,32.58,33.06,55.55,55.80,63.91,91.38,92.68,105.25,105.56,105.85,109.72,110.74,114.26,159.98,160.54,162.13,162.47,162.72,163.49,163.53,165.03,203.36,203.86,204.33 |
» ²ÂÄãϲ»¶
0703µ÷¼Á£¬Ò»Ö¾Ô¸Ìì½ò´óѧ319·Ö
ÒѾÓÐ18È˻ظ´
Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
334·Ö»úеר˶Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
±¾¿ÆÖ£ÖÝ´óѧ£¬Ò»Ö¾Ô¸»ª¶«Ê¦·¶´óѧ282Çóµ÷¼Á
ÒѾÓÐ16È˻ظ´
305·ÖÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤085600 310·ÖÇóµ÷¼Á
ÒѾÓÐ21È˻ظ´
»¯¹¤Ñ§Ë¶ 285Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
328Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ9È˻ظ´
081700ѧ˶£¬323·Ö£¬Ò»Ö¾Ô¸Öйúº£Ñó´óѧÇóµ÷¼ÁѧУ
ÒѾÓÐ18È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇóÖú΢Æ×Êý¾Ý²éѯ
ÒѾÓÐ4È˻ظ´
ÇóÖú΢Æ×Êý¾Ý²éѯ
ÒѾÓÐ4È˻ظ´
ÇóÖúÁ½¸ö»¯ºÏÎïµÄ΢Æ×Êý¾Ý²éѯ
ÒѾÓÐ3È˻ظ´
ÇóÖúÒ»¸ö»¯ºÏÎïµÄ΢Æ×Êý¾Ý
ÒѾÓÐ4È˻ظ´
΢Æ×Êý¾Ý²éѯÇóÖú
ÒѾÓÐ3È˻ظ´
ÇóÖú΢Æ×Êý¾Ý²éѯ
ÒѾÓÐ4È˻ظ´
ÇóÖú΢Æ×Êý¾Ý ÖØ½±
ÒѾÓÐ3È˻ظ´
΢Æ×Êý¾ÝÇóÖú ¼±±ÏÒµ
ÒѾÓÐ4È˻ظ´
ÇóÖú΢Æ×Êý¾Ý£¬Ð»Ð»
ÒѾÓÐ3È˻ظ´
ÇóÖú΢Æ×Êý¾Ý£¬Ð»Ð»
ÒѾÓÐ3È˻ظ´
ÇóÖú΢Æ×Êý¾Ý£¬Ð»Ð»
ÒѾÓÐ4È˻ظ´
ÇóÖúͨ¹ý΢Æ×²éѯ»¯ºÏÎï½á¹¹
ÒѾÓÐ4È˻ظ´
ÇóÖú΢Æ×Êý¾Ý
ÒѾÓÐ3È˻ظ´
[ÇóÖú]ÄÄλºÃÈËѧУ¿ÉÒÔʹÓÃ΢Æ×Êý¾Ý¿â£¬°ïÎÒ¼ìË÷¼¸¸ö»¯ºÏÎïµÄĸºË¡£Ð»Ð»£¡
ÒѾÓÐ4È˻ظ´

Ц¶à»á»³ÔÐ
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 1216 (½²Ê¦)
- ½ð±Ò: 9788.1
- É¢½ð: 610
- ºì»¨: 40
- ɳ·¢: 3
- Ìû×Ó: 2723
- ÔÚÏß: 1284.6Сʱ
- ³æºÅ: 2010893
- ×¢²á: 2012-09-18
- ÐÔ±ð: GG
- רҵ: ÌìÈ»Óлú»¯Ñ§
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Çç·ïÒÇ: ½ð±Ò+5, ¡ï¡ï¡ïºÜÓаïÖú 2013-09-07 19:43:38
Çç·ïÒÇ(¶¹¸ç´ú·¢): ½ð±Ò+5, лл 2013-09-11 10:18:17
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Çç·ïÒÇ: ½ð±Ò+5, ¡ï¡ï¡ïºÜÓаïÖú 2013-09-07 19:43:38
Çç·ïÒÇ(¶¹¸ç´ú·¢): ½ð±Ò+5, лл 2013-09-11 10:18:17
|
²éѯ½á¹û£º¹²²éµ½1¸ö»¯ºÏÎï(²éѯ½á¹û½ö¹©²Î¿¼) 1 . ebractelatinoside B C25H30O13 ÏàËÆ¶È:61.5% Acta Pharmaceutica Sinica 1999 Vol 34 526-529 ACETOPHENONE DERIVATIVES FROM EUPHORBIA EBRACTEOLATA HAYATA Wang Wenxiang (Wang WX) and Ding Xingbao (Ding XB) Structure 13C NMR ̼Æ×Ä£Äâͼ |
2Â¥2013-09-07 19:41:58














»Ø¸´´ËÂ¥